Bulletin
Investor Alert

New York Markets After Hours

Personalis Inc.

NAS: PSNL

GO
/marketstate/country/us

After Hours

 --Real time quotes

May 10, 2021, 5:49 p.m.

/zigman2/quotes/212754973/composite

$

19.50

Change

0.00 0.00%

Volume

Volume 9,579

Real time quotes

/zigman2/quotes/212754973/composite

Today's close

$ 22.75

$ 19.50

Change

-3.25 -14.29%

Day low

Day high

$19.39

$22.41

Open

52 week low

52 week high

$10.02

$53.46

Open

Insider Actions for Personalis Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
04/01/2021 Richard O. Chen
Chief Scientific Officer
12,517   Disposition at $25.69 per share. 321,561
04/01/2021 Richard O. Chen
Chief Scientific Officer
6,260   Disposition at $25.96 per share. 162,509
04/01/2021 Richard O. Chen
Chief Scientific Officer
21,223   Disposition at $25.61 per share. 543,521
04/01/2021 Richard O. Chen
Chief Scientific Officer
12,517   Derivative/Non-derivative trans. at $0.44 per share. 5,507
03/17/2021 Aaron Tachibana
Chief Financial Officer
2,446   Disposition at $26.73 per share. 65,381
03/17/2021 Richard O. Chen
Chief Scientific Officer
1,130   Disposition at $26.73 per share. 30,204
03/06/2021 Woodrow A. Myers
Director
2,610   Award at $0 per share. 0
03/02/2021 Aaron Tachibana
Chief Financial Officer
3,022   Disposition at $32.6 per share. 98,517
03/02/2021 Richard O. Chen
Chief Scientific Officer
345   Disposition at $32.6 per share. 11,247
02/01/2021 Richard O. Chen
Chief Scientific Officer
11,022   Disposition at $38.8 per share. 427,653
02/01/2021 Richard O. Chen
Chief Scientific Officer
2,400   Disposition at $38.12 per share. 91,488
02/01/2021 Richard O. Chen
Chief Scientific Officer
20,059   Disposition at $38.83 per share. 778,890
02/01/2021 Richard O. Chen
Chief Scientific Officer
6,519   Disposition at $38.19 per share. 248,960
02/01/2021 Richard O. Chen
Chief Scientific Officer
13,422   Derivative/Non-derivative trans. at $0.44 per share. 5,905
12/17/2020 Aaron Tachibana
Chief Financial Officer
2,391   Disposition at $36.37 per share. 86,960
12/17/2020 Richard O. Chen
Chief Scientific Officer
1,087   Disposition at $36.37 per share. 39,534
12/02/2020 Aaron Tachibana
Chief Financial Officer
2,926   Disposition at $27.76 per share. 81,225
12/02/2020 Richard O. Chen
Chief Scientific Officer
293   Disposition at $27.76 per share. 8,133
12/01/2020 Richard O. Chen
Chief Scientific Officer
25,612   Disposition at $28.14 per share. 720,721
12/01/2020 Richard O. Chen
Chief Scientific Officer
14,388   Disposition at $27.75 per share. 399,267
12/01/2020 Richard O. Chen
Chief Scientific Officer
40,000   Derivative/Non-derivative trans. at $0.44 per share. 17,600
10/20/2020 Abingworth LLP
130,486   Disposition at $27.66 per share. 3,609,242
10/19/2020 Abingworth LLP
196,423   Disposition at $27.86 per share. 5,472,344

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
2 Purchases
7 Sales
15,127
46,943
Last 6 months
4 Purchases
17 Sales
68,549
133,640
Last 12 months
8 Purchases
37 Sales
593,018
942,882

Officers and Executives

Mr. John S. West
President, Chief Executive Officer & Director
Mr. Aaron Tachibana
Chief Financial Officer
Dr. Xavier Paliard
Vice President-Immunology, Research & Development
Dr. Richard O. Chen
Chief Scientific Officer
Ms. Carol J. Tillis
Vice President-Finance & Administration
Dr. Leslie Grab
Vice President-Intellectual Property
Dr. John Lyle
Vice President-Assay Research & Development
Dr. Stephane Mouradian
Vice President-Business Development
Dr. Christian D. Haudenschild
Vice President-Genomic Services
Dr. Rena McClory
Vice President-Marketing
Ms. Caroline Corner
Investor Relations Contact
Ms. Susan Moriconi
Chief Human Resources Officer & VP-People
Mr. Stephen M. Moore
General Counsel
Dr. Jonathan J. MacQuitty
Chairman
Mr. Arthur Blaine Bowman
Independent Director
Dr. Alan B. Colowick
Independent Director
Mr. Paul A. Ricci
Independent Director
Ms. Karin Eastham
Independent Director
Dr. Woodrow A. Myers
Independent Director
Mr. Kenneth E. Ludlum
Independent Director
Link to MarketWatch's Slice.